This site is for health care professionals only.
Our 4 Bold Approaches to Cancer Treatment

Approved Products

Solid Tumors

Solid Tumors

  

KISQALI® (ribociclib)

LUTATHERA® (lutetium Lu 177 dotatate)

PIQRAY® (alpelisib)

TAFINLAR® (dabrafenib) + MEKINIST® (trametinib)

Malignant Hematology

Malignant Hematology

  

KYMRIAH® (tisagenlecleucel) CAR-T Cell Therapy

RYDAPT® (midostaurin)

Non-malignant Hematology

Non-malignant Hematology

  

ADAKVEO® (crizanlizumab-tcma)